Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 19, 2018 3:35:55 GMT -5
Said Casey Jr. as the little engine struggled up the hill. To me, MNKD is the perfect embodiment of Casey Jr and his struggle to reach the mountain's top. Mike has driven MNKD from the brink of death's grip to the (IMHO)eventually point where Casey Jr. reaches the mountain's peak and with a final "I think I can" he crests over the mountain, never to look back. The same can be said for all the people who have doubted this company that is so close to chanting "I thought I could. I thought I could." They have never believed in us, and never will.
Here's to, "I thought I could. I thought I could."
|
|
|
|
Post by sexychefski on May 19, 2018 5:00:34 GMT -5
As long as it's not, "Blaine is a pain"
|
|
|
|
Post by sportsrancho on May 19, 2018 7:22:09 GMT -5
We are the little engine that could. Where would we be in this world if people gave up on their visions? Al had the vision, Mike grabbed the torch. And with his confidence created the team. Bill did the same with Vdex. It’s amazing how many people who say they have no position in the stock spend so much time every day talking about us longs. And then the longs who have let paranoia, “shorts” and wishy-washiness set in and get into their psyche. It’s time to ignore the noise and keep your eyes on the track:-) youtu.be/UuDK0xIZFTo |
|
|
|
Post by peppy on May 19, 2018 7:28:26 GMT -5
Said Casey Jr. as the little engine struggled up the hill. To me, MNKD is the perfect embodiment of Casey Jr and his struggle to reach the mountain's top. Mike has driven MNKD from the brink of death's grip to the (IMHO)eventually point where Casey Jr. reaches the mountain's peak and with a final "I think I can" he crests over the mountain, never to look back. The same can be said for all the people who have doubted this company that is so close to chanting "I thought I could. I thought I could." They have never believed in us, and never will. Here's to, "I thought I could. I thought I could." Good thing we have continuous glucose monitoring, or all the lies trying to close down MANNKIND/Afrezza could be believed. This insulin is sweet.  |
|
|
|
Post by babaoriley on May 19, 2018 11:28:19 GMT -5
We are the little engine that could. Where would we be in this world if people gave up on their visions? Al had the vision, Mike grabbed the torch. And with his confidence created the team. Bill did the same with Vdex. It’s amazing how many people who say they have no position in the stock spend so much time every day talking about us longs. And then the longs who have let paranoia, “shorts” and wishy-washiness set in and get into their psyche. It’s time to ignore the noise and keep your eyes on the track:-) youtu.be/UuDK0xIZFToI see one difference in the little engine that could, if I remember it correctly. I don't think the little engine that could ever got to the very top of the hill, looked down the other side, and then slid back down the hill, ending in a heap.  But, after some major repairs, our little engine is climbing that hill again. |
|
|
|
Post by buyitonsale on May 19, 2018 13:03:31 GMT -5
Little engine needs debt based financing to keep the gas tank full on the way up the mountain...
|
|
|
|
Post by goyocafe on May 20, 2018 5:28:45 GMT -5
I’m anxious to see how much momentum Dr Randall can muster going into the ADA symposium. If it’s true that the current CMO of the ADA has actually been in contact with Dr Randall, that bodes very well for this story to get better before the end of June.
It may be the story of the little engine, but the conductor’s name is E.F.Hutton III.
|
|
|
|
Post by falconquest on May 20, 2018 7:25:12 GMT -5
We are the little engine that could. Where would we be in this world if people gave up on their visions? Al had the vision, Mike grabbed the torch. And with his confidence created the team. Bill did the same with Vdex. It’s amazing how many people who say they have no position in the stock spend so much time every day talking about us longs. And then the longs who have let paranoia, “shorts” and wishy-washiness set in and get into their psyche. It’s time to ignore the noise and keep your eyes on the track:-) youtu.be/UuDK0xIZFToSports, as many here know, I am one of those people who have no position in this stock. I am NOT one of those people who "spend so much time everyday talking about us longs" as a matter of fact, I post very little here but do read quite a bit. While I do respect the optimism expressed by those who continue to hang on to their shares the truth is that an investment in Mannkind has been an unmitigated disaster for nearly every investor other than those who were short. BTW, for the record I have never shorted a stock in my life.
The fact is, most investors in this company are so far down they have no choice but to hold on and hope Mike can pull it all together. I guess I'm confused by these "feel good" posts. They have a certain "Stockholm Syndrome" feel to them. I am not completely negative however. I do believe that Mike has assembled probably the best team that Mannkind has ever had. Let's not forget that it was Al's goal to sell the company. I believe that he genuinely believed that big pharma would beat a path to his door not only for Afrezza but for Technosphere once approved. He was wrong and we are now attempting to salvage the company before funding dries up completely.
I am cautiously optimistic about the outcome of the ADA Conference and sincerely hope that Dr. Kendall can have a positive impact on the script count but until that happens the share price will continue to languish. I believe there is a middle ground between unbridled enthusiasm and outright negativity which is a realistic approach. That is the one I espouse. I may just have to become an investor again if they can really get things moving but until then I will remain on the sidelines. Good luck to all, I wish you the best.
|
|
|
|
Post by winstonsmith on May 20, 2018 7:54:35 GMT -5
Buzz killer post.....ha ha
|
|
|
|
Post by sportsrancho on May 20, 2018 8:37:35 GMT -5
We are the little engine that could. Where would we be in this world if people gave up on their visions? Al had the vision, Mike grabbed the torch. And with his confidence created the team. Bill did the same with Vdex. It’s amazing how many people who say they have no position in the stock spend so much time every day talking about us longs. And then the longs who have let paranoia, “shorts” and wishy-washiness set in and get into their psyche. It’s time to ignore the noise and keep your eyes on the track:-) youtu.be/UuDK0xIZFToSports, as many here know, I am one of those people who have no position in this stock. I am NOT one of those people who "spend so much time everyday talking about us longs" as a matter of fact, I post very little here but do read quite a bit. While I do respect the optimism expressed by those who continue to hang on to their shares the truth is that an investment in Mannkind has been an unmitigated disaster for nearly every investor other than those who were short. BTW, for the record I have never shorted a stock in my life.
The fact is, most investors in this company are so far down they have no choice but to hold on and hope Mike can pull it all together. I guess I'm confused by these "feel good" posts. They have a certain "Stockholm Syndrome" feel to them. I am not completely negative however. I do believe that Mike has assembled probably the best team that Mannkind has ever had. Let's not forget that it was Al's goal to sell the company. I believe that he genuinely believed that big pharma would beat a path to his door not only for Afrezza but for Technosphere once approved. He was wrong and we are now attempting to salvage the company before funding dries up completely.
I am cautiously optimistic about the outcome of the ADA Conference and sincerely hope that Dr. Kendall can have a positive impact on the script count but until that happens the share price will continue to languish. I believe there is a middle ground between unbridled enthusiasm and outright negativity which is a realistic approach. That is the one I espouse. I may just have to become an investor again if they can really get things moving but until then I will remain on the sidelines. Good luck to all, I wish you the best.
Stockholm Syndrome? Give me a break. In the first place I know you’re not one of those people, far from it. But I just met Dr. Kendall. My client and his son got to spend a good amount of time with Mike, and Jake took Afrezza at the shareholder dinner. Along with Joey and Denise. You weren’t there, you didn’t hear what Dr. Kendall said about Afrezza compared to other barbaric insulin's. In addition to that I’m not all that much underwater so I don’t see why it’s so hard to understand. (And I’m very aware Al wanted to sell the company). When you have friends on Afrezza you’re rooting for the company to do well:-) Bottom line is diversification in your portfolio keeps you sane while you’re waiting for the laggards to catch up. I feel good about the company, I feel good about the people that work at the company. I have just as much right to feel good as other people have to feel bad... it’s just my personality to be a diehard. I don’t give up, and from what I can tell nobody at Mannkind is about to give up either! |
|
|
|
Post by mnholdem on May 20, 2018 20:43:49 GMT -5
CMO David Kendall MD recently made a statement to the effect that Technosphere Insulin (Afrezza) is ten years ahead of today's diabetes treatments. Alfred E Mann believed that to be true, as do many who invested in the company he founded. TI is the only insulin in the world whose PK/PD profile nearly matches that of a healthy pancreas and medical science has only recently begun to unravel the complexity of functions and signaling that are executed by a healthy human pancreas. Some think that merely injecting RAA insulin earlier will duplicate the first phase insulin release that Afrezza but it doesn't come close. Also, a healthy pancreas doesn't leave excess insulin in the bloodstream beyond what's needed. There is other indigenous signaling involved, such as glycogen release to bring blood sugars back into balance after first and second phase insulin release. Failure to achieve first phase can throw signaling out of whack. Again, simulating a healthy pancreas has benefits that the medical community is only beginning to understand.
Dr. Kendall also stated that the ADA has recently initiated contact with MannKind. Normally, it's the other way around. Remember, MannKind's new CMO was the former Chief Scientific and Medical Officer for the American Diabetes Association. In addition, the former President of the American Diabetes Association, John E. Anderson MD, currently is a member of MannKind's newly formed Scientific Advisory Board. Dr. Kendall recently stated that he believes that Technosphere Insulin (Afrezza) will become the Standard of Care for treating both Type 1 and Type 2 diabetes.
Powerful words by someone who has powerful friends in the medical community.
I have strongly believed in the science behind Technosphere Insulin since I first researched it many years ago, when I first recognized that what Alfred Mann said was true. Afrezza can revolutionize diabetes treatment in many ways. If used in early intensive insulin therapy, it can result in remission of the disease. Many clinical studies have validated this. It's not a theory. Several of the authors of those studies that have been published over the years have lamented the fact that subcutaneous injections of insulin are simply too slow and also the idea of insulin injections is resisted by patients diagnosed with early stage diabetes.
Technosphere delivers ultra fast acting insulin using pulmonary administration via an inert, harmless particle that is the exact size needed to reach the alveoli and transport immediately into the blood stream, within one minute of the speed at which a healthy pancreas does the same thing. Technosphere Insulin is a shining example of what is termed a "disruptive" technology - innovations that are often so different from conventional wisdom that physicians simply don't believe it at first. However, with the support and council of a remarkable Chief Medical Officer, Scientific Advisory Board and a CEO who is driven to fulfill Alfred Mann's vision, I think that MannKind Corporation will soon be making believers in Technosphere Insulin out of the healthcare professionals within the diabetes treatment industry.
Today the science and understanding of diabetes is advancing at a rapidly accelerated rate, thanks largely to CGM and other modern marvels. The ADA and AACE have been paying attention, even to the point that the ADA recently announced that it will be updating the Diabetes Standards of Care more frequently than once a year. They've acknowledged that the advancements are accelerating so fast that it's become essential for them to keep pace.
I have never sold a share of MNKD and I continue to accumulate. I do this because I believe that the science will prevail. Naysayers will continue to ridicule and lambast MannKind Corporation, much like the scientific community did in regard to Galileo's revelations.
Good fortune all. 
|
|
|
|
Post by falconquest on May 20, 2018 21:26:52 GMT -5
Well said MN, it is my sincere hope for all those who have been here for many years that you are right. They all deserve it!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 20, 2018 21:48:18 GMT -5
CMO David Kendall MD recently made a statement to the effect that Technosphere Insulin (Afrezza) is ten years ahead of today's diabetes treatments. Alfred E Mann believed that to be true, as do many who invested in the company he founded. TI is the only insulin in the world whose PK/PD profile nearly matches that of a healthy pancreas and medical science has only recently begun to unravel the complexity of functions and signaling that are executed by a healthy human pancreas. Some think that merely injecting RAA insulin earlier will duplicate the first phase insulin release that Afrezza but it doesn't come close. Also, a healthy pancreas doesn't leave excess insulin in the bloodstream beyond what's needed. There is other indigenous signaling involved, such as glycogen release to bring blood sugars back into balance after first and second phase insulin release. Failure to achieve first phase can throw signaling out of whack. Again, simulating a healthy pancreas has benefits that the medical community is only beginning to understand.
Dr. Kendall also stated that the ADA has recently initiated contact with MannKind. Normally, it's the other way around. Remember, MannKind's new CMO was the former Chief Scientific and Medical Officer for the American Diabetes Association. In addition, the former President of the American Diabetes Association, John E. Anderson MD, currently is a member of MannKind's newly formed Scientific Advisory Board. Dr. Kendall recently stated that he believes that Technosphere Insulin (Afrezza) will become the Standard of Care for treating both Type 1 and Type 2 diabetes.
Powerful words by someone who has powerful friends in the medical community.
I have strongly believed in the science behind Technosphere Insulin since I first researched it many years ago, when I first recognized that what Alfred Mann said was true. Afrezza can revolutionize diabetes treatment in many ways. If used in early intensive insulin therapy, it can result in remission of the disease. Many clinical studies have validated this. It's not a theory. Several of the authors of those studies that have been published over the years have lamented the fact that subcutaneous injections of insulin are simply too slow and also the idea of insulin injections is resisted by patients diagnosed with early stage diabetes.
Technosphere delivers ultra fast acting insulin using pulmonary administration via an inert, harmless particle that is the exact size needed to reach the alveoli and transport immediately into the blood stream, within one minute of the speed at which a healthy pancreas does the same thing. Technosphere Insulin is a shining example of what is termed a "disruptive" technology - innovations that are often so different from conventional wisdom that physicians simply don't believe it at first. However, with the support and council of a remarkable Chief Medical Officer, Scientific Advisory Board and a CEO who is driven to fulfill Alfred Mann's vision, I think that MannKind Corporation will soon be making believers in Technosphere Insulin out of the healthcare professionals within the diabetes treatment industry.
Today the science and understanding of diabetes is advancing at a rapidly accelerated rate, thanks largely to CGM and other modern marvels. The ADA and AACE have been paying attention, even to the point that the ADA recently announced that it will be updating the Diabetes Standards of Care more frequently than once a year. They've acknowledged that the advancements are accelerating so fast that it's become essential for them to keep pace.
I have never sold a share of MNKD and I continue to accumulate. I do this because I believe that the science will prevail. Naysayers will continue to ridicule and lambast MannKind Corporation, much like the scientific community did in regard to Galileo's revelations.
Good fortune all.
This is why I COMPLETELY agree with you. Certain analysts only see black and white, namely script counts and growth that is lackluster(at this time), and that is fine. Those individuals shall remain anonymous, per Liane's instructions. Yet, seeing the full spectrum of colors that represent MNKD and its potential is also important in my opinion. Least we forget, Al's vision: take care of the patients and the rest will take care of itself. Additionally, his previous companies were sold, making investors money. All the while focusing on patients. This is where we are very lucky. We have Mike who has this same vision, but he is also keen in the ways of business. So, while anonymous writers have been clear in their black and white analysises, things can turn on a dime. And if they do, I am very curious to see how these same bashers, will account for this in their analysis. Still long. Still buying weekly. |
|
|
|
Post by nylefty on May 20, 2018 22:39:24 GMT -5
Well said, mnholdem. Your post was especially welcome after all the negativity that's been spewed here recently. |
|
|
|
Post by sweedee79 on May 20, 2018 22:53:24 GMT -5
In response to falconquest ... I'm not far underwater at all.. I sold presplit and didn't get back in til the stock was trading at 2$ post split .. After that I held until last Oct. During the rally to near 7$.. I had a trailing stop on my shares and managed to sell at 5$ a share .. up 34k during that run.. I got back in with an average of 2.75 .. so now I'm down approx. 8k I'm guessing.. Not too shabby.. My cost avg. Has always been low never much over 2$.. I avg. down. And while I perhaps could have made more money elsewhere I believe in the story.. And you never know when things are going to turn around or how fast.. I believe Afrezza is the best thing that has happened for the treatment of diabetes since the invention of insulin therapy.. And I don't regret a minute of my investment or what I saw Afrezza do for my dad... or the amazing people on this board I've sort of come to know a little bit.. admire and respect.. Also as Sports pointed out investors should have a diversified portfolio.. I have cannibas stocks.. Aphria and Canopy have been doing quite well..and will more than likely jump.. Otc to major US exchange.. I also have some gold.. And for value and dividends thinking about adding XOM 😁 |
|
But, after some major repairs, our little engine is climbing that hill again. 
